Clinical trial
Investigation of the Natural Progression of Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance.
NCT04102423 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Natural Progression of Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance.
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 3, 2020
- Completion date
- September 15, 2033
- Enrollment
- 306 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clonal cytopenia of undetermined significance, clonal hematopoiesis of indeterminate potential